Patritumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Patritumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Patritumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Patritumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Patritumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Patritumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Patritumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Patritumab.

• AnifrolumabMODERAT

  Mengonsumsi Anifrolumab bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anifrolumab is combined with Patritumab.

• Anthrax immune globulin humanMODERAT

  Mengonsumsi Anthrax immune globulin human bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Patritumab.

• Antilymphocyte immunoglobulin (horse)MODERAT

  Mengonsumsi Antilymphocyte immunoglobulin (horse) bersama Patritumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Patritumab.